123 related articles for article (PubMed ID: 17987225)
1. Imaging as a tool in drug development.
Strack T
Drugs Today (Barc); 2007 Oct; 43(10):725-36. PubMed ID: 17987225
[TBL] [Abstract][Full Text] [Related]
2. Imaging in drug development.
Nairne J; Iveson PB; Meijer A
Prog Med Chem; 2015; 54():231-80. PubMed ID: 25727706
[TBL] [Abstract][Full Text] [Related]
3. A rational regulatory approach for positron emission tomography imaging probes: from "first in man" to NDA approval and reimbursement.
Barrio JR; Marcus CS; Hung JC; Keppler JS
Mol Imaging Biol; 2004; 6(6):361-7. PubMed ID: 15564146
[TBL] [Abstract][Full Text] [Related]
4. [Molecular imaging-based early-phase and exploratory clinical research].
Watanabe Y
Yakugaku Zasshi; 2013; 133(2):187-95. PubMed ID: 23370512
[TBL] [Abstract][Full Text] [Related]
5. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
6. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
Harapanhalli RS
Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
[TBL] [Abstract][Full Text] [Related]
7. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
[TBL] [Abstract][Full Text] [Related]
8. New technologies and directed agents for applications of cancer imaging.
Atri M
J Clin Oncol; 2006 Jul; 24(20):3299-308. PubMed ID: 16829654
[TBL] [Abstract][Full Text] [Related]
9. In vivo molecular imaging biomarkers: clinical pharmacology's new "PET"?
Nutt R; Vento LJ; Ridinger MH
Clin Pharmacol Ther; 2007 Jun; 81(6):792-5. PubMed ID: 17505491
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
[TBL] [Abstract][Full Text] [Related]
11. Workflow in Simultaneous PET/MRI.
Barbosa Fde G; von Schulthess G; Veit-Haibach P
Semin Nucl Med; 2015 Jul; 45(4):332-44. PubMed ID: 26050660
[TBL] [Abstract][Full Text] [Related]
12. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
13. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in hybrid molecular imaging systems.
Lee JS; Kim JH
Semin Musculoskelet Radiol; 2014 Apr; 18(2):103-22. PubMed ID: 24715444
[TBL] [Abstract][Full Text] [Related]
15. Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging.
Ripa RS; Kjær A
Biomed Res Int; 2015; 2015():914516. PubMed ID: 25695091
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/magnetic resonance imaging evaluation of lung cancer: current status and future prospects.
Yoon SH; Goo JM; Lee SM; Park CM; Seo HJ; Cheon GJ
J Thorac Imaging; 2014 Jan; 29(1):4-16. PubMed ID: 24296699
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous PET-MRI: a new approach for functional and morphological imaging.
Judenhofer MS; Wehrl HF; Newport DF; Catana C; Siegel SB; Becker M; Thielscher A; Kneilling M; Lichy MP; Eichner M; Klingel K; Reischl G; Widmaier S; Röcken M; Nutt RE; Machulla HJ; Uludag K; Cherry SR; Claussen CD; Pichler BJ
Nat Med; 2008 Apr; 14(4):459-65. PubMed ID: 18376410
[TBL] [Abstract][Full Text] [Related]
18. Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas.
Dhermain FG; Hau P; Lanfermann H; Jacobs AH; van den Bent MJ
Lancet Neurol; 2010 Sep; 9(9):906-20. PubMed ID: 20705518
[TBL] [Abstract][Full Text] [Related]
19. Combined PET/MRI: one step further in multimodality imaging.
Sauter AW; Wehrl HF; Kolb A; Judenhofer MS; Pichler BJ
Trends Mol Med; 2010 Nov; 16(11):508-15. PubMed ID: 20851684
[TBL] [Abstract][Full Text] [Related]
20. Brown adipose tissue in humans: detection and functional analysis using PET (positron emission tomography), MRI (magnetic resonance imaging), and DECT (dual energy computed tomography).
Borga M; Virtanen KA; Romu T; Leinhard OD; Persson A; Nuutila P; Enerbäck S
Methods Enzymol; 2014; 537():141-59. PubMed ID: 24480345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
